| __timestamp | Amicus Therapeutics, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 40786000 |
| Thursday, January 1, 2015 | 47269000 | 47876000 |
| Friday, January 1, 2016 | 71151000 | 52035000 |
| Sunday, January 1, 2017 | 88671000 | 55348000 |
| Monday, January 1, 2018 | 127200000 | 65276000 |
| Tuesday, January 1, 2019 | 169861000 | 82720000 |
| Wednesday, January 1, 2020 | 156407000 | 89118000 |
| Friday, January 1, 2021 | 192710000 | 181193000 |
| Saturday, January 1, 2022 | 213041000 | 174078000 |
| Sunday, January 1, 2023 | 275270000 | 184232000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing expenses is crucial for sustainable growth. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Veracyte, Inc. and Amicus Therapeutics, Inc. from 2014 to 2023. Over this period, Amicus Therapeutics saw a staggering 1,230% increase in SG&A expenses, peaking in 2023. Meanwhile, Veracyte, Inc. experienced a 352% rise, with a notable surge in 2021, reaching 98% of Amicus's expenses. This trend highlights Amicus's aggressive expansion strategy, while Veracyte's steady growth reflects a more conservative approach. Understanding these financial dynamics offers insights into each company's operational strategies and market positioning. As the biotech industry evolves, monitoring such financial metrics becomes essential for investors and stakeholders aiming to make informed decisions.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.
Alnylam Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Intra-Cellular Therapies, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Bio-Techne Corporation or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Sarepta Therapeutics, Inc. vs Veracyte, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and Veracyte, Inc.
Amneal Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
Veracyte, Inc. vs Merus N.V.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ACADIA Pharmaceuticals Inc.
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Iovance Biotherapeutics, Inc.